20+
Pure Oncology Focus
100%
Oncology Indications Covered
10+
3
AI Powered Platforms
Years in Oncology
III
OUR SERVICE PORTFOLIO
Three Disciplines.
One Continuous Edge.
We turn oncology intelligence into market advantage across your asset's life — from the first signal to post-launch defense.
PILLAR IÂ -Â THE RADAR
-
Competitive Landscape & Threat Assessment
​
-
Pipeline & Clinical Trial Surveillance
​
-
Conference Intelligence (Pre/Live/Post)​
​
-
Ongoing CI MonitoringÂ
​
-
Social, Digital & Sentiment Tracking
"Know every competitor's move before it becomes a threat."
Competitive & Conference Intelligence
I
THE RIGOR UNDERNEATH - decodeMR
Powered by Primary Research
Every pillar is grounded in evidence from the field — physicians, patients, and payers — through decodeMR, our in-house primary market research team.
-
Therapy Area Strategy
​
-
Asset / Indication Prioritization
​
-
Early Asset & Licensing-Opportunity Evaluation
​
-
Portfolio & Pipeline Strategy
​
-
Market Sizing, Forecasting & Patient-Population Assessment
PILLAR IIÂ -Â THE DECISIONS
Therapy Area & Portfolio Strategy
II
"Choose where to play — and prove what it's worth."
PILLAR IIIÂ -Â THE ACTIVATION
Launch, Commercialization & Access
III
-
Launch Strategy & Competitive Readiness
​
-
War-Gaming & Competitive Simulation
​
-
Brand Positioning & Differentiation
​
-
KOL Strategy & Engagement Mapping
​
-
Market Access, Pricing & HTA Strategy
"Win at launch — and protect the position after it."
Heading 1
Where We Add Value
Intelligence for Every Stage of Your Asset's Journey
From pipeline entry to post-launch defense — select a stage to see the Oncofocus services that matter most.
AI-POWERED PLATFORMS
Three Proprietary Tools That Power Our Intelligence
Always-on oncology intelligence — so our strategists start every engagement steps ahead.
Strategic Intelligence Platform
Live competitive intelligence dashboard — pipeline tracking, trial monitoring, competitive event alerts, and strategic briefings in one place.
​
-
Live pipeline & trial tracking across all indications
​
-
Competitive event alerts on filings, approvals & readouts
​
-
Monthly strategic briefings by oncology specialists
Trial Site & Investigator Intelligence
Pinpoint where every competing trial is running and who is running it, so feasibility and site selection start from current, registry-verified data instead of stale lists.
​
-
Site and investigator mapping (PI, study chair, sub-investigators) across ClinicalTrials.gov and country-specific registries
​
-
Site and investigator availability modeled from start, primary completion, and completion dates
​
-
Every location tied to indication, phase, and sponsor for feasibility and competitive site benchmarking
Label Forecast Intelligence
Model the label an asset could realistically earn before pivotal design is locked, with aspirational, base, and minimal-competitive scenarios built from regulatory precedent, society guidance, and competitor filings.
​
-
Aspirational, base, and minimal-competitive label scenarios for any asset entering pivotal development
​
-
Evidence base spanning regulatory guidance, society recommendations (NCCN, ASCO, ESMO, ACR, EULAR), and competitor and precedent protocols
​
-
Gap analysis of label requested versus granted across close competitors and prior approvals
WHY ONCOFOCUS
Pure Oncology Focus
Only oncology, 100% of the time. No generalist frameworks.
Executive Calibre Insight
Built for CCOs, CSOs, CMOs, VPs defining an asset's commercial future.
The Difference Between Plan and Strategy
We exist because oncology is different. The competitive dynamics, the clinical complexity, and the speed of data—no generalist consulting firm can match the depth of a team built entirely around this one therapeutic area.
Intelligence-Led
Real data from trials, congresses, payers, physicians—curated by oncology specialists.
Speed to Insight
Rapid delivery cycles, not months-long consulting timelines.
Client Perspectives
“
Oncofocus gave us a competitive landscape so detailed it changed our entire launch sequencing strategy. Exceptional depth.
JR, Chief Commercial Officer, Mid-size Oncology Biopharma
“
The CImple platform is now essential at every congress. Our team walks into ASCO fully briefed — it's transformed how we operate.
SM, VP Medical Affairs, Global Oncology Company
“
Their war-gaming workshop was the most valuable day our launch team had. Surfaced gaps we didn't know existed, months ahead of go-live.